HBK Investments’s CVS Health CVS Stock Holding History

HBK Investments’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,200	Closed	-$636K	–	284
2023 Q2	$636K	Buy	+9,200	New	+$655K	﹤0.01%	312
2022 Q3	–	Sell	-53,900	Closed	-$4.99M	–	449
2022 Q2	$4.99M	Sell	53,900 -2,900	-5%	-$283K	0.03%	216
2022 Q1	$5.75M	Buy	+56,800	New	+$5.97M	0.02%	234
2021 Q4	–	Sell	-106,500	Closed	-$9.04M	–	741
2021 Q3	$9.04M	Buy	106,500 +42,400	+66%	+$3.55M	0.04%	134
2021 Q2	$5.35M	Buy	+64,100	New	+$5.25M	0.02%	280
2021 Q1	–	Sell	-19,800	Closed	-$1.35M	–	887
2020 Q4	$1.35M	Sell	19,800 -123,100	-86%	-$8.01M	0.01%	472
2020 Q3	$8.35M	Sell	142,900 -29,600	-17%	-$1.84M	0.06%	134
2020 Q2	$11.2M	Buy	+172,500	New	+$10.9M	0.15%	76
2020 Q1	–	Sell	-387,700	Closed	-$28.8M	–	141
2019 Q4	$28.8M	Buy	387,700 +139,000	+56%	+$9.76M	0.28%	28
2019 Q3	$15.7M	Sell	248,700 -31,500	-11%	-$1.87M	0.2%	63
2019 Q2	$15.3M	Buy	+280,200	New	+$15.1M	0.13%	65

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HBK Investments's CVS Position: Q3 2022 in Review

HBK Investments sold out of CVS Health (CVS) in Q3 2022, closing a stake of 4,079 shares — an estimated $378K sold.

HBK Investments first reported a position in CVS in Q3 2013 and held it in 12 quarters. The position peaked at $8.36M in Q3 2020. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

HBK Investments reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
HBK Investments sold 4,079 CVS Health shares in Q3 2022, an estimated $378K.
HBK Investments first reported a position in CVS Health in Q3 2013 and held it in 12 quarters.
HBK Investments's CVS Health position peaked at $8.36M in Q3 2020.
2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on HBK Investments's 13F filing for Q3 2022, filed 14 Nov 2022.